Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Why Inovio Pharmaceuticals (INO) Stock Is Down 40%
Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower by 40% to $2.23 during Friday's session after the company priced a public offering of 10 million shares of common stock and accompanying warrants.
伊诺维奥制药公司（纳斯达克：INO）的股票在周五的交易中下跌了40%，目前交易价格为2.23美元，此前该公司以1000万股普通股及相应的Warrants进行公开发行。
The shares are priced at $3.00 each, with warrants exercisable at $3.76 per share, potentially raising $30 million in gross proceeds before expenses and commissions.
每股定价为3.00美元，Warrants的行使价格为每股3.76美元，预计在扣除费用和佣金之前筹集3000万美元的总收入。
The offering, managed by Oppenheimer & Co., Citizens JMP and Stephens Inc., is set to close on December 16, pending customary conditions.
此次发行由Oppenheimer & Co.、Citizens JMP和Stephens Inc.共同管理，预计将于12月16日结束，待满足一般条件。
Read Also: Hershey Merger Talks Melt: Did High Cocoa Prices, Mondelez Buyback Program Hurt Deal?
另请阅读：好时合并谈判破灭：高可可价格和Mondelez回购计划是否影响了交易？
Should I Sell My INO Stock?
我应该卖出我的INO股票吗？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在决定持有或卖出股票时，投资者应考虑他们的时间跨度、未实现收益和总回报。
Shares of Inovio Pharmaceuticals have decreased by 51.14% in the past year. An investor who bought shares of Inovio Pharmaceuticals at the beginning of the year would take a loss of $4.49 per share if they sold it today. The stock has fallen 52.2% over the past month, meaning an investor who bought shares on Nov. 1 would see a capital loss of $3.24.
伊诺维奥制药的股票在过去一年中下降了51.14%。如果一位投资者在年初购买了伊诺维奥制药的股票，今天卖出将会损失每股4.49美元。该股票在过去一个月中下跌了52.2%，这意味着如果投资者在11月1日购买股票，将会看到每股3.24美元的资本损失。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要访问高级图表和分析工具及股票数据，请查看Benzinga PRO。免费试用。
INO has a 52-week high of $14.75 and a 52-week low of $2.20.
伊诺维奥制药的52周最高价为14.75美元，最低价为2.20美元。
